Let's remember that Nanologix is in the business of rapid diagnostics, not cures or treatment. Because a company decides, for financial reasons, not to pursue their testing of a treatment does not diminish the need to detect any outbreak in the most expedient way to isolate and prevent the spread of whatever outbreak that may occur. Two totally different avenues being pursued.

Viruses mutate and evolve, always have, always will, and usually come back with an attitude. If the n assay can be adaptable to be adjusted to make these detections in a rapid manner then we are well ahead of the game.

I believe that this is realized and that the continued testing and refinement will continue as detection is the critical element in combatting any viral/biological threat.